KRAS and cancer: The prevailing hypothesis is that chronic inflammation leads to increased cell proliferation and decreased immunosurveillance by the downregulation of the tumor-suppressing genes p16, p53, and SMAD 4 and the upregulation of the oncogenic KRAS gene, thus favoring the onset and growth of cancer [17,79,218].